Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Phase 4 Study in Adult Patients With Chronic Plaque Psoriasis to Evaluate the Immune Response to Pneumococcal Vaccine in Subjects Treated With Alefacept

NCT00493324 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.

NCT NCT00493324
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00493324 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Phase 4 Study in Adult Patients With Chronic Plaque Psoriasis to Evaluate the Immune Response to Pneumococcal Vaccine in Subjects Treated With Alefacept
Lead sponsor
Astellas Pharma Inc
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2007
Completion date
July 31, 2008
Enrollment
43 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

chronic plaque psoriasis